Advertisement

Index by author

December 01, 2023; Volume 104,Issue 6

B

  1. Bhave, Kieran

    1. Substituted Cysteine Modification and Protection with n-Alkyl-MTS Reagents Quantifies Steric Changes Induced by a Mutation in Anesthetic Binding Sites on GABA Type A Receptors
      Kieran Bhave and Stuart A. Forman
      Molecular Pharmacology December 2023, 104 (6) 266-274; DOI: https://doi.org/10.1124/molpharm.123.000719

F

  1. Forman, Stuart A.

    1. Substituted Cysteine Modification and Protection with n-Alkyl-MTS Reagents Quantifies Steric Changes Induced by a Mutation in Anesthetic Binding Sites on GABA Type A Receptors
      Kieran Bhave and Stuart A. Forman
      Molecular Pharmacology December 2023, 104 (6) 266-274; DOI: https://doi.org/10.1124/molpharm.123.000719

H

  1. Hagenbuch, Bruno

    1. Molecular Mechanisms of Organic Anion Transporting Polypeptide–Mediated Organic Anion Clearance at the Blood–Cerebrospinal Fluid Barrier
      Austin Sun, Bruno Hagenbuch, Edward J. Kelly and Joanne Wang
      Molecular Pharmacology December 2023, 104 (6) 255-265; DOI: https://doi.org/10.1124/molpharm.123.000703

I

  1. Iino, Masamitsu

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  2. Ishida, Ryosuke

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  3. Ishigami-Yuasa, Mari

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

K

  1. Kagechika, Hiroyuki

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  2. Kanemaru, Kazunori

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  3. Kelly, Edward J.

    1. Molecular Mechanisms of Organic Anion Transporting Polypeptide–Mediated Organic Anion Clearance at the Blood–Cerebrospinal Fluid Barrier
      Austin Sun, Bruno Hagenbuch, Edward J. Kelly and Joanne Wang
      Molecular Pharmacology December 2023, 104 (6) 255-265; DOI: https://doi.org/10.1124/molpharm.123.000703

  4. Kodama, Masami

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  5. Kurebayashi, Nagomi

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

L

  1. Li, Pengyuan

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

  2. Liu, Chenglong

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

  3. Lu, Wei

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

M

  1. Ma-Lauer, Yue

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

  2. Miura, Aya

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  3. Mori, Shuichi

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  4. Morimoto, Sachio

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  5. Murayama, Takashi

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

N

  1. Nishio, Hajime

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

S

  1. Sakurai, Takashi

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  2. Su, Zhuang

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

  3. Sugihara, Masami

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

  4. Sun, Austin

    1. Molecular Mechanisms of Organic Anion Transporting Polypeptide–Mediated Organic Anion Clearance at the Blood–Cerebrospinal Fluid Barrier
      Austin Sun, Bruno Hagenbuch, Edward J. Kelly and Joanne Wang
      Molecular Pharmacology December 2023, 104 (6) 255-265; DOI: https://doi.org/10.1124/molpharm.123.000703

  5. Suzuki, Junji

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

T

  1. Takenaka, Mai

    1. Open Access
      Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring
      Mai Takenaka, Masami Kodama, Takashi Murayama, Mari Ishigami-Yuasa, Shuichi Mori, Ryosuke Ishida, Junji Suzuki, Kazunori Kanemaru, Masami Sugihara, Masamitsu Iino, Aya Miura, Hajime Nishio, Sachio Morimoto, Hiroyuki Kagechika, Takashi Sakurai and Nagomi Kurebayashi
      Molecular Pharmacology December 2023, 104 (6) 275-286; DOI: https://doi.org/10.1124/molpharm.123.000720

V

  1. von Brunn, Albrecht

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

W

  1. Wang, Joanne

    1. Molecular Mechanisms of Organic Anion Transporting Polypeptide–Mediated Organic Anion Clearance at the Blood–Cerebrospinal Fluid Barrier
      Austin Sun, Bruno Hagenbuch, Edward J. Kelly and Joanne Wang
      Molecular Pharmacology December 2023, 104 (6) 255-265; DOI: https://doi.org/10.1124/molpharm.123.000703

  2. Wu, Aihua

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

Y

  1. Yang, Fan

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

Z

  1. Zhang, Hao

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587

  2. Zhu, Di

    1. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation
      Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn and Di Zhu
      Molecular Pharmacology December 2023, 104 (6) 239-254; DOI: https://doi.org/10.1124/molpharm.122.000587
Back to top

In this issue

Advertisement